These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49. Increasing antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in Finland. Manninen R; Huovinen P; Nissinen A J Antimicrob Chemother; 1997 Sep; 40(3):387-92. PubMed ID: 9338492 [TBL] [Abstract][Full Text] [Related]
50. Moraxella catarrhalis endocarditis: case report and review of the literature. Stefanou J; Agelopoulou AV; Sipsas NV; Smilakou N; Avlami A Scand J Infect Dis; 2000; 32(2):217-8. PubMed ID: 10826914 [TBL] [Abstract][Full Text] [Related]
51. Antibiotic susceptibility patterns of community-acquired respiratory isolates of Moraxella catarrhalis in western Europe and in the USA. The Alexander Project Collaborative Group. Berk SL; Kalbfleisch JH J Antimicrob Chemother; 1996 Jul; 38 Suppl A():85-96. PubMed ID: 8858475 [TBL] [Abstract][Full Text] [Related]
52. Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999. Hoban DJ; Doern GV; Fluit AC; Roussel-Delvallez M; Jones RN Clin Infect Dis; 2001 May; 32 Suppl 2():S81-93. PubMed ID: 11320449 [TBL] [Abstract][Full Text] [Related]
53. β-Lactamase production and antibiotic susceptibility pattern of Moraxella catarrhalis isolates collected from two county hospitals in China. Shi W; Wen D; Chen C; Yuan L; Gao W; Tang P; Cheng X; Yao K BMC Microbiol; 2018 Jul; 18(1):77. PubMed ID: 30029595 [TBL] [Abstract][Full Text] [Related]
54. Antibiotic resistance in respiratory tract isolates of Haemophilus influenzae and Moraxella catarrhalis collected from across Canada in 1997-1998. Zhanel GG; Karlowsky JA; Low DE; Hoban DJ J Antimicrob Chemother; 2000 May; 45(5):655-62. PubMed ID: 10797089 [TBL] [Abstract][Full Text] [Related]
55. Contemporary prevalence of BRO beta-lactamases in Moraxella catarrhalis: report from the SENTRY antimicrobial surveillance program (North America, 1997 to 2004). Deshpande LM; Sader HS; Fritsche TR; Jones RN J Clin Microbiol; 2006 Oct; 44(10):3775-7. PubMed ID: 17021108 [TBL] [Abstract][Full Text] [Related]
57. Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the respiratory surveillance program study: microbiology from the medical office practice environment. Pfaller MA; Ehrhardt AF; Jones RN Am J Med; 2001 Dec; 111 Suppl 9A():4S-12S; discussion 36S-38S. PubMed ID: 11755437 [TBL] [Abstract][Full Text] [Related]
58. Effect of inoculum size on the in-vitro susceptibility to beta-lactam antibiotics of Moraxella catarrhalis isolates of different beta-lactamase types. Yeo SF; Livermore DM J Med Microbiol; 1994 Apr; 40(4):252-5. PubMed ID: 8151675 [TBL] [Abstract][Full Text] [Related]